Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ...
On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...
There will be an open session Nov. 20 at city hall and a statutory public meeting during the Dec. 9 council meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback